Browsing by Author Ferrer, Isidro (Ferrer Abizanda)

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 27 to 46 of 168 < previous   next >
Issue DateTitleAuthor(s)
1993Calbindin D-28K and parvalbumin immunoreactivity in the frontal cortex in patients with frontal lobe dementia of non-Alzheimer type associated with amyotrophic lateral sclerosisFerrer, Isidro (Ferrer Abizanda); Tuñón, Teresa; Serrano Piñol, M. Teresa; Casas, Rosaura; Alcántara Horrillo, Soledad; Zújar, M. J.; Rivera, R. M.
1-Nov-2018Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous systemAymerich, Maria S.; Aso, Ester; Abellanas, Miguel A.; Tolon, Rosa M.; Ramos, Jose A.; Ferrer, Isidro (Ferrer Abizanda); Romero, Julian; Fernández-Ruiz, Javier
5-Mar-2014Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinicAsó, Ester; Ferrer, Isidro (Ferrer Abizanda)
5-Mar-2014Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinicAsó, Ester; Ferrer, Isidro (Ferrer Abizanda)
1-Jan-2015Cannabis-based medicine reduces multiple pathological processes in AβPP/PS1 miceAsó, Ester; Sànchez, Àlex (Sànchez Pla); Vegas Lozano, Esteban; Maldonado, Rafael, 1961-; Ferrer, Isidro (Ferrer Abizanda)
2012CB1 agonist ACEA protects neurons and reduces the cognitive impairment of AβPP/PS1 miceAsó, Ester; Palomer, Ernest; Juvés, Salvador; Maldonado, Rafael, 1961-; Muñoz, Francisco J.; Ferrer, Isidro (Ferrer Abizanda)
4-Dec-2015CB1 cannabinoid receptor enrichment in the ependymal region of the adult human spinal cordPaniagua Torija, Beatriz; Arevalo Martin, Angel; Ferrer, Isidro (Ferrer Abizanda); Molina Holgado, Eduardo; Garcia Ovejero, Daniel
1-Jun-2013CB2 Cannabinoid Receptor Agonist Ameliorates Alzheimer-Like Phenotype in AβPP/PS1 MiceAsó, Ester; Juvés, Salvador; Maldonado, Rafael, 1961-; Ferrer, Isidro (Ferrer Abizanda)
May-2016CB2 cannabinoid receptor as potential target against alzheimer's diseaseAsó, Ester; Ferrer, Isidro (Ferrer Abizanda)
1-Feb-2019Cerebrospinal fluid neurofilament light in suspected sporadic Creutzfeldt-Jakob diseaseKanata, Eirini; Golanska, Ewa; Villar Piqué, Anna; Karsanidou, Aikaterini; Dafou, Dimitra; Xanthopoulos, Konstantinos; Schmitz, Matthias; Ferrer, Isidro (Ferrer Abizanda); Karch, André; Sikorska, Beata; Liberski, Pawel P.; Sklaviadis, Theodoros; Zerr, Inga; Llorens Torres, Franc
Jun-2018Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseasesZerr, Inga; Schmitz, Matthias; Karch, André; Villar Piqué, Anna; Kanata, Eirini; Golanska, Ewa; Diaz-Lucena, Daniela; Llorens Torres, Franc; Hermann, Peter; Knipper, Tobias; Goebel, Stefan; Varges, Daniela; Sklaviadis, Theodoros; Sikorska, Beata; Liberski, Pawel P.; Ladogana, Anna Sánchez; Ferrer, Isidro (Ferrer Abizanda); Zetterberg, Henrik; Blennow, Kaj; Calero, Miguel; Sánchez del Valle Díaz, Raquel; Baldeiras, Inês
1-Apr-2019Cerebrospinal fluid total prion protein in the spectrum of prion diseasesVillar Piqué, Anna; Schmitz, Matthias; Lachmann, Ingolf; Karch, André; Calero, Olga; Stehmann, Christ; Sarros, Shannon; Ladogana, Anna Sánchez; Poleggi, Anna; Santana, Isabel; Ferrer, Isidro (Ferrer Abizanda); Mitrova, Eva; áková, Dana; Pocchiari, Maurizio; Baldeiras, Inês; Calero, Miguel; Collins, Steven J.; Geschwind, Michael D.; Sánchez del Valle Díaz, Raquel; Zerr, Inga; Llorens Torres, Franc
14-Jun-2011Clinical and myopathological evaluation of early- and late-onset subtypes of myofibrillar myopathyOlivé i Plana, Montserrat; Odgerel, Zagaa; Martínez, Amaia; Poza, Juan José; García Bragado, Federico; Zabalza, Ramón J.; Jericó, Ivonne; González Mera, Laura; Shatunov, Alexei; Lee, Hee Suk; Armstrong i Morón, Judith; Maraví, Elías; Ramos Arroyo, María; Pascual Calvet, Jordi; Navarro, Carmen; Paradas, Carmen; Huerta, Mariano; Márquez, Fabian; Gutierrez Rivas, Eduardo; Pou, Adolf; Ferrer, Isidro (Ferrer Abizanda); Goldfarb, Lev G.
1-Jan-2015Clinical correlations with Lewy body pathology in LRRK2-related Parkinson diseaseKalia, Lorraine V.; Lang, Anthony E.; Hazrati, Lili-Naz; Fujioka, Shinsuke; Wszolek, Zbigniew K.; Dickson, Dennis W.; Ross, Owen A.; Van Deerlin, Vivianna M.; Trojanowski, John Q.; Hurtig, Howard I.; Alcalay, Roy N.; Marder, Karen S.; Clark, Lorraine N.; Gaig Ventura, Carles; Tolosa, Eduardo; Ruiz-Martínez, Javier; Marti-Masso, Jose F.; Ferrer, Isidro (Ferrer Abizanda); López de Munain, Adolfo; Goldman, Samuel M.; Schüle, Birgitt; Langston, J. William; Aasly, Jan O.; Giordana, Maria T.; Bonifati, Vincenzo; Puschmann, Andreas; Canesi, Margherita; Pezzoli, Gianni; Maues De Paula, Andre; Hasegawa, Kazuko; Duyckaerts, Charles; Brice, Alexis; Stoessl, A. Jon; Marras, Connie
1-Jan-1995Clinical, neuropathologic and genetic studies of a large spinocerebellar ataxia type 1 (SCA1) kindred: (CAG)n expansion and early premonitory signs and symptomsGenís, David; Matilla-Dueñas, Antoni; Volpini Bertrán, Víctor; Rosell, J.; Dávalos, Antoni; Ferrer, Isidro (Ferrer Abizanda); Molins, Albert; Estivill, Xavier, 1955-
11-Oct-2012Coexistence of protease sensitive and resistant prion protein in 129VV homozygous sporadic Creutzfeldt-Jakob disease: a case reportRodríguez Martínez, Ana B.; López de Munain, Adolfo; Ferrer, Isidro (Ferrer Abizanda); Zarranz, Juan J.; Atarés, Begoña; Villagra, Nuria T.; Arteagoitia, José M.; Garrido, Joseba M.; Juste, Ramón A.
8-Apr-2019Combined transcriptomics and proteomics in frontal cortex area 8 in frontotemporal lobar degeneration linked to C9ORF72 expansionAndrés Benito, Pol; Gelpi, Ellen; Povedano, Mònica; Ausin, Karina; Fernández Irigoyen, Joaquín; Santamaría, Enrique; Ferrer, Isidro (Ferrer Abizanda)
1-Jan-2015Complex Inflammation mRNA-Related Response in ALS Is Region DependentBerjaoui, Sara; Povedano, Mònica; Garcia Esparcia, Paula; Carmona Murillo, Margarita; Asó, Ester; Ferrer, Isidro (Ferrer Abizanda)
2003Cromogranina A en adenomas hipofisarios humanosVidal, Noemí; Paules, Mª José; Villabona Artero, Carlos; Gómez, José Manuel; Ferrer, Isidro (Ferrer Abizanda)
23-Apr-2014Crtc1 activates a transcriptional program deregulated at early Alzheimer's disease-related stagesParra-Damas, A.; Valero, J.; Chen, M.; España, J.; Martín, Elsa; Ferrer, Isidro (Ferrer Abizanda); Rodríguez-Alvarez, J.; Saura, C. A.